An internationally recognized neuro-oncologist has joined McGovern Medical School to establish a new translational research program focused on cancer biology and therapeutic resistance.
An analysis of an uncharted area of the genome could help pave the way for new treatments for intractable spinal cord injuries, according to a preclinical study led by McGovern Medical School neuroscientists. The results were published recently in the journal Scientific Reports.
Pediatricians are invited to attend the second annual Pediatric Neuroscience Symposium May 14. “Children with Neurological and Neurosurgical Conditions: An Update for Pediatricians” will include an overview of current and changing concepts in the care of children with neurological conditions.
Neuroscientists have been awarded a $1.8 million National Institutes of Health (NIH) grant to explore a leading-edge treatment for speech problems experienced by many people following a stroke, traumatic brain injury, or other neurological disorder.
Cutting-edge management of neurological and neurosurgical emergencies and critical care is the focus of Mischer Neuroscience Institute’s Neuro ICU Symposium March 23-25 at the JW Marriot, 5150 Westheimer.
When researchers look for the genetic causes of diseases impairing the ability of millions to speak, move, or think, investigators typically focus on the tiny part of the human genome linked to 25,000 or so protein-producing genes.
Christine Buckley, executive director of The Brain Aneurysm Foundation, Arlicia Albert, brain aneurysm survivor and patient of Dr. P. Roc Chen, assistant professor of neurosurgery at The UTHealth Medical School, from left, are shown during the foundation’s Research Grant Awards Symposium Sept. 20, 2015 at Hotel Za Za. Chen was the featured speaker during the event and Albert delivered the survivor’s presentation.